UPDATE 1 - Fitch cuts Merck&#39;s triple-A rating by two notches
689119
Fitch Ratings on Thursday cut Merck &amp; Co. Inc.&#39;s (MRK.N: Quote, Profile, Research) top &quot;AAA&quot; rating by two notches, citing its withdrawal of the arthritis drug Vioxx and subsequent
145358
Merck said lost Vioxx sales and estimated customer returns totaled $492 million in the third quarter, and the recall slashed net income by about $553 million.
163353
On Nov. 1, 2004, Standard &amp; Poor&#39;s Ratings Services placed its &#39;AAA&#39; corporate credit and senior unsecured debt ratings on Merck &amp; Co.
515664
Pharmaceutical giant Merck &amp; Co., under siege over revenues lost since it recalled arthritis drug Vioxx, will have cut about 5,100 jobs by year&#39;s end, 700 more than first planned, and will slash costs by $2.4 billion over four years, chairman and CEO
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
252722
Shares in US drug maker Merck tumbled nearly 10% on Monday after a press report suggesting the firm may have ignored problems with one of its drugs.
125028
Drug company Merck has removed its painkiller Vioxx because of data showing an increased risk of heart attack and stroke.
22097
Standard &amp; Poor&#39;s on Monday said it may cut its ratings on Merck &amp; Co Inc.(MRK.N: Quote, Profile, Research) , citing increasing concern about possible litigation relating to Merck&#39;s arthritis drug Vioxx.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
437541
Shares of Merck and Co. plunged nearly 27 percent Thursday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.
398157
An experimental cholesterol treatment touted by drugmaker Merck &amp; Co. significantly reduced artery-clogging fats in late-stage testing, but it got a mixed reception from Wall Street analysts Tuesday.
745465
A third major debt ratings agency has stripped Merck &#38; Co. of its top credit grade, lowering the drug maker's classification by three notches amid concerns stemming from its recall of the arthritis drug Vioxx.
474839
The Toronto stock market posted a small gain today, pushed higher by the gold sector, but drug company Merck &amp; Co. took the Dow Jones industrial average into the red after taking its arthritis drug Vioxx off the market.
323641
The share price of US drugs giant Merck falls to an eight-year low after it announces that it has been forced to withdraw a key drug on side effect fears.
115343
WHAT a pill Vioxx turned out to be for Merck. Between 50 cents and 60 cents a share were lopped off expected earnings this year after the US pharmaceutical giant gave up defending its painkiller in public
467183
NEW YORK - Investors sent stocks mostly lower Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...